Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00031408 · ClinicalTrials.gov registry record
Consent for Use of Stored Patient Specimens for Future Testing
A clinical trial of HIV Infections, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- Active
- Registry status
- 17,444
- Enrollment target
- 20
- Study locations
NCT00031408: Active study of HIV Infections, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
NCT00031408 is a study of HIV Infections that is active but no longer recruiting, run by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. The registered enrollment target is 17,444 participants, above the 414-participant average among 542 other HIV Infections trials with a reported enrollment target (4114% higher). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00031408, a study of HIV Infections, is active but no longer recruiting, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- ACTIVE NOT RECRUITING
- Registry status
- 17,444 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
Conditions Studied
Study Locations (20)
California
- Univ of Southern California / LA County USC Med Ctr - Los Angeles
- Charles Drew Medical Center - Los Angeles
- UCLA CARE Ctr - Los Angeles
- Univ of California, San Diego - San Diego
- Univ of California San Francisco - San Francisco
- San Mateo AIDS Program / Stanford Univ - Stanford
- Stanford Univ Med Ctr - Stanford
- Willow Clinic / Stanford Univ - Stanford
- Harbor General/UCLA - Torrance
Illinois
- Northwestern Univ Med School - Chicago
- Rush Presbyterian - Saint Luke's Med Ctr - Chicago
- The CORE Ctr - Chicago
Indiana
- Indiana Univ Hosp - Indianapolis
- Methodist Hosp of Indiana / Life Care Clinic - Indianapolis
- Wishard Hosp - Indianapolis
Colorado
- Univ of Colorado Health Sciences Ctr - Denver
District of Columbia
- Georgetown Univ Med Ctr - Washington D.C.
Florida
- Univ of Miami School of Medicine - Miami
Georgia
- Emory Univ - Atlanta
Iowa
- Department of Internal Medicine, University of Iowa Hospitals & Clinics CRS (1504) - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,444 participants |
| Start Date | 2002-02-13 |
| Est. Completion | 2027-12-31 |
What the registry record for NCT00031408 still lists
NCT00031408 is an observational study that tracks outcomes without assigning an intervention. Its 17,444 participants enrollment target places it among the larger protocols in the corpus, above the 414-participant average among 542 other HIV Infections trials with a reported enrollment target (4114% higher).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00031408 names 20 study sites across 8 states, led by California, Illinois, Indiana.
Frequently Asked Questions
What is clinical trial NCT00031408 about?
NCT00031408 is a clinical study titled "Consent for Use of Stored Patient Specimens for Future Testing". The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
What is the current status of trial NCT00031408?
This trial is currently active not recruiting. The enrollment target is 17,444 participants. The study started on 2002-02-13. Estimated completion is 2027-12-31.
What conditions does trial NCT00031408 study?
This clinical trial studies the following conditions: HIV Infections.
Who is sponsoring clinical trial NCT00031408?
This trial is sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00031408 being conducted?
This trial has 20 study locations across California, Colorado, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00031408's enrollment target sits among peer trials
17,444 3rd of 542 higher than 540 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06272110 · 17,500 participants
Promoting Equitable Access to Language Services in Health and Human Services
- NCT07290361 · 17,587 participants · NA
Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT)
- NCT06245187 · 17,198 participants
Get With the Guidelines Atrial Fibrillation Registry
- NCT07108660 · 17,800 participants · NA
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI